CHEARS

Use tab to navigate through the menu items.

FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions

FDA Approves Eticovo (etanercept-ykro), a Biosimilar to Enbrel

FDA Approves Dovato (dolutegravir/lamivudine) for HIV-1 Infection

FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Ob

FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution)

FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma

FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta

Despite Criticisms – Dsuvia (Sufentanil) made it's way to market

FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lun

2

You are now subscribed to CHEARS

bottom of page